The board of directors of Johnson & Johnson (NYSE:JNJ) approved a common stock cash dividend of USD1.06 per share for the third quarter of 2021, the company reported on Monday.

Shareholders of record at the close of business on 24 August 2021 will receive the dividend payment on 7 September 2021 and the ex-dividend date is 23 August 2021.

Johnson & Johnson researches and develops, manufactures and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical and Medical Devices.

The company was founded in 1886 and is based in New Brunswick, New Jersey, USA.